VIVONICS INC — Department of Health and Human Services SBIR Phase I: NIAID
VIVONICS INC — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $166,793
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- NIAID
- Solicitation
- PA14-071
- NAICS
- —
- Place of performance
- MA
- Period
- 2016-07-01 → 2018-05-31
Description
DESCRIPTION provided by applicant In the US there are over pediatric recipients of organs every year To prevent organ rejection these patients must strictly adhere to treatment programs that require a combination of immunosuppressants and steroids that must be taken throughout the day and must be taken for the rest of their lives Adolescence is a time period when patients are often tasked with taking on greater responsibility for their care as they transition to adulthood and adult based medical care settings However current research indicates that adolescents are the least adherent group to their post transplant medication regimen with rates reported as high as nearly of this population These high rates of medication non adherence have significant implications for health outcomes and the concomitant financial cost of medical care For example adolescent kidney transplant recipients have lower graft survival rates at and years post transplant of any age group except the elderly Non adherence can result in rejection episodes increased hospitalizations and frequency of medical follow ups and death Thus maintaining adherence is critical not only for the transition to adulthood but for long term health and quality of life Improving Medical Prescription Adherence by Leveraging Mobile Technology iMedPAL provides a novel multifaceted approach to addressing medication non adherence and ultimately improving health outcomes for the adolescent transplant recipient population Vivonics is partnered with the Transplant Center at Childrenandapos s Hospital Boston for demonstrating the clinical feasibility of the iMedPAL system To assess the marketability of the iMedPAL system for use by the proposed targeted population and beyond we are working with e Pill LCC the leading distributor of medical devices designed to improve Patient Compliance and Medication Adherence in the US PUBLIC HEALTH RELEVANCE For adolescents who have received an organ transplant maintaining adherence to their post transplant medication regimen is critical not only for the transition to adulthood but for long term health and quality of life Adolescentandapos s high rates of medication non adherence have significant implications for health outcomes and the concomitant financial cost of medical care Novel uses of mobile technology can offer a means of encouraging long term adherence by integrating evidence based strategies into a hands on readily accessible format